With associated neuroprotection and anti-inflammatory activities, Geraniol (GE) has the potential to treat antidepressant-like behaviors in CUMS-induced depression mouse models, possibly by inhibiting the NF-κB pathway activation. This evidence concerns the gene NFKB1 and major depressive disorder.